NeuBase Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
NeuBase Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2022.
  • NeuBase Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $992K, a 984% increase year-over-year.
  • NeuBase Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $1.54M.
  • NeuBase Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$458K, a 140% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $1.16M.
  • NeuBase Therapeutics, Inc. annual Nonoperating Income (Expense) for 2018 was $667K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$458K -$1.61M -140% Oct 1, 2021 Sep 30, 2022 10-K 2022-12-21
2021 $1.16M Oct 1, 2020 Sep 30, 2021 10-K 2022-12-21
2018 $667K +$698K Oct 1, 2017 Sep 30, 2018 10-K 2019-01-03
2017 -$30.9K +$1.14M +97.4% Oct 1, 2016 Sep 30, 2017 10-K 2019-01-03
2016 -$1.17M -$3.78M -145% Oct 1, 2015 Sep 30, 2016 10-K 2017-12-15
2015 $2.61M +$2.62M Oct 1, 2014 Sep 30, 2015 10-K 2016-12-22
2014 -$7.74K +$1.02M +99.3% Oct 1, 2013 Sep 30, 2014 10-K 2016-12-22
2013 -$1.03M -$2.86M -156% Oct 1, 2012 Sep 30, 2013 10-K 2015-12-14
2012 $1.83M +$5.69M Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
2011 -$3.86M -$5.37M -356% Oct 1, 2010 Sep 30, 2011 10-K 2013-01-09
2010 $1.51M Oct 1, 2009 Sep 30, 2010 10-K/A 2012-01-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.